Advertisement
Advertisement

RLMD

RLMD logo

Relmada Therapeutics, Inc. Common Stock

6.51
USD
Sponsored
-0.26
-3.84%
Jun 24, 15:58 UTC -4
Closed
exchange

Pre-Market

6.59

+0.08
+1.20%

Relmada Therapeutics, Inc. Common Stock Financial Snapshot

Market Cap
691.66M
Beta
0.44
Earnings Per Share (EPS)
-1.45
Price-to-Book (P/B) Ratio
6.45
Operating Margin
--
Total Debt/Equity (D/E)
0.00%
P/E Ratio
--
Return on Equity (ROE)
-170.83%
Current Ratio
14.62%
Free Cash Flow
-45.79M

Earnings Chart

Advertisement